Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-18-057789

Options or other derivatives

  • Director acquired 50,044 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Cook Jennifer E. Director 2018-11-06 Grant or award · Stock Option (right to buy) +50,044 50,044 D
Loading xslF345X03/doc4.xml…